Techspec schreef op 17 dec 2018 om 18:07:
Dan hadden ze daar toch echt naar verwezen in hun artikel van Mei 2018 maar dat deden ze niet.
Ze herhaalde slechts wat men al in januari 2017 had vastgesteld, namelijk;
Uit het nieuwe artikel Mei 2018;
Nexium has been shown in the laboratory to potentially target two proteins that are known to be released from the placenta in abnormal amounts in pregnant women destined to develop pre-eclampsia.
Uit het oude artikel Jan 2017;
So we tested in the lab to see whether or not we could block these proteins and whether we could protect a mother's blood vessels," she said.
Dr Hannan said they found that they could block the proteins from being released from the diseased placenta, as well as protect the mother's blood vessels.
Dr Hannan said international trials were set to begin soon in South Africa, where there are high rates of pre-eclampsia.
"We've currently got a clinical trial running with our clinical collaborators over in South Africa and we're about three-quarters of the way through recruiting patients," she said.
"We should have results for that towards the end of this year."